JAMA OphthalmologyPeer-Reviewed Publication JAMA Network FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail About The Study: The results of this study suggest a modest increase in the risk of nonarteritic anterior ischemic optic neuropathy among individuals with type 2 diabetes associated with semaglutide use, smaller than that previously reported, and warranting further investigation into the clinical implications of this association. Corresponding Author: To contact the...
Tag: <span>optic neuropathy</span>
Post
Semaglutide doubles risk for nonarteritic anterior ischemic optic neuropathy
by Lori Solomon Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a study published online Dec. 18 in the International Journal of Retina and Vitreous. Jakob Grauslund, D.M.Sci., Ph.D., M.D., from Odense University Hospital in Denmark, and colleagues prospectively evaluated the use...
Post
What to know about anterior ischemic optic neuropathy
Anterior ischemic optic neuropathy (AION) occurs when there is not enough blood flow into the eye. This causes damage to the optic nerve, quickly leading to vision loss. There are two subtypes of AION including arteritic (A-AION) and nonarteritic (NA-AION). NA-AION makes up nearly 85% of all AION cases. Both conditions arise when there is...